Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Current Assets (2014 - 2026)

Updated

Zevra Therapeutics (ZVRA) recorded Current Assets of $251.3 million in Q2 2026, up 11.0% from $226.34 million a year earlier and up 9.3% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Zevra Therapeutics reported Current Assets of $223.01 million, up 159.2% from FY2024.

  • Annual Current Assets has a five-year compound annual growth rate of 92.7% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $86.03 million in FY2024 (-1.0%), $86.94 million in FY2023 (-6.4%), $92.83 million in FY2022 (-19.3%) and $115.06 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2014.
  • On a year-over-year basis, Current Assets has increased for six consecutive quarters, with growth averaging 93.9% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 271.7% in Q2 2025, against a decline of 41.1% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $229.97 million (Q1 2026), $223.01 million (Q4 2025) and $225.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 59.77 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.67 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 27.97 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 12.54 Bn
10 Zevra Therapeutics 672.94 Mn -139.77 Mn 38.18 Mn 251.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 251.30 Mn
Mar 31, 2026 229.97 Mn
Dec 31, 2025 223.01 Mn
Sep 30, 2025 225.12 Mn
Jun 30, 2025 226.34 Mn
Mar 31, 2025 81.57 Mn
Dec 31, 2024 86.03 Mn
Sep 30, 2024 99.44 Mn
Jun 30, 2024 60.89 Mn
Mar 31, 2024 62.89 Mn
Dec 31, 2023 86.94 Mn
Sep 30, 2023 137.01 Mn
Jun 30, 2023 103.43 Mn
Mar 31, 2023 104.28 Mn
Dec 31, 2022 92.83 Mn
Sep 30, 2022 85.13 Mn
Jun 30, 2022 87.44 Mn
Mar 31, 2022 105.78 Mn
Dec 31, 2021 115.06 Mn
Sep 30, 2021 134.63 Mn
API Access

Zevra Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY